Master protocol
Showing 1 - 25 of >10,000
Tumors, Child, Adolescent Trial in Leiden (Ramucirumab, Cyclophosphamide, Vinorelbine)
Recruiting
- Neoplasms
- +2 more
- Ramucirumab
- +7 more
-
Leiden, NetherlandsLeids Universitair Medisch Centrum
Aug 14, 2023
Precision Medicine Treatment for Refractory Solid Tumors
Recruiting
- Refractory Solid Tumors
- Next Generation Sequencing
-
Tianjin, Tianjin, ChinaTianjin Medical University Second Hospital
Sep 2, 2023
Acute Myeloid Leukemia in Children Trial (Standard Intervention, Investigational Intervention)
Not yet recruiting
- Acute Myeloid Leukemia in Children
- Standard Intervention
- Investigational Intervention
- (no location specified)
Aug 8, 2023
Solid Tumor Trial in United States (drug, combination product, biological)
Recruiting
- Solid Tumor
- Pembrolizumab
- +2 more
-
Sacramento, California
- +6 more
Jan 3, 2023
Empowering Mechanobiology Translation Research in Breast Cancer
Recruiting
- Breast Cancer
- Observational
-
Bergamo, Italy
- +6 more
Apr 26, 2022
Prostate Cancer, Recurrent Adenocarcinoma, Liver Cancer Trial in Boston (MRI Simulator, Radiation Therapy)
Recruiting
- Prostate Cancer
- +3 more
- MRI Simulator
- Radiation Therapy
-
Boston, Massachusetts
- +1 more
Jan 9, 2023
CIRculating CANcer MAster-Protocol
Not yet recruiting
- Adult With Solid Cancer
- Blood sampling for biomarker analysis (microRNA, circulating DNA…)
-
Pierre-Bénite, FranceHopital Lyon Sud
Oct 21, 2021
RESPIRATORY SYNCYTIAL VIRUS (RSV) Trial (Substudy A (Study Intervention), Substudy A (Placebo), Substudy B)
Not yet recruiting
- RESPIRATORY SYNCYTIAL VIRUS (RSV)
- Substudy A (Study Intervention)
- +2 more
- (no location specified)
Apr 24, 2023
Cancer Harboring BRAF Alterations Trial (FORE8394, Cobicistat)
Not yet recruiting
- Cancer Harboring BRAF Alterations
- (no location specified)
Aug 15, 2022
NSCLC, Metastatic NSCLC Trial (Tislelizumab, BGB-A445, LBL-007)
Not yet recruiting
- Non-small Cell Lung Cancer
- Metastatic Non-small Cell Lung Cancer
- Tislelizumab
- +7 more
- (no location specified)
Dec 14, 2022
Lymphoma, B-Cell Trial in Vancouver, Toronto, Montreal (Venetoclax, RiTUXimab Injection, Rituximab SC)
Recruiting
- Lymphoma, B-Cell
- Venetoclax
- +5 more
-
Vancouver, British Columbia, Canada
- +2 more
Jan 24, 2022
Acute Myeloid Leukemia, MDS Trial (SPRX002, ARC-T)
Not yet recruiting
- Acute Myeloid Leukemia
- Myelodysplastic Syndromes
- SPRX002
- ARC-T
- (no location specified)
Jul 12, 2022
Participants 18 Years of Age or Older - Lite
Recruiting
- HIV/AIDS
-
Los Angeles, California
- +8 more
Aug 26, 2022
2019 Novel Coronavirus Disease, 2019 Novel Coronavirus Infection, 2019-nCoV Disease Trial in Miami (Famotidine, Celecoxib,
Active, not recruiting
- 2019 Novel Coronavirus Disease
- +11 more
- Famotidine
- +2 more
-
Miami, FloridaUS02-04: Integrated Health Solutions
Aug 15, 2022
Heart; Surgery, Heart, Functional Disturbance as Result, Pain, Postoperative, Nursing Caries Trial (Care Protocol)
Not yet recruiting
- Heart; Surgery, Heart, Functional Disturbance as Result
- +2 more
- Care Protocol
- (no location specified)
Jun 13, 2023
Immunocompromised Patients Trial in Switzerland (Moderna COVID-19 Vaccine, mRNA-1273 (100 µg), Pfizer-BioNTech COVID-19 Vaccine
Active, not recruiting
- Immunocompromised Patients
- Moderna COVID-19 Vaccine, mRNA-1273 (100 μg)
- Pfizer-BioNTech COVID-19 Vaccine BNT162b2 (30 µg)( Comirnaty®)
-
Basel, Switzerland
- +3 more
Oct 18, 2022
HIV, Breast Cancer Trial (MARVIN, MARVIN-Pharma, MARVINA)
Not yet recruiting
- HIV Infections
- Breast Cancer
- MARVIN
- +2 more
- (no location specified)
Mar 27, 2023
Plasma Cell Myeloma Refractory Trial in Worldwide (Isatuximab SAR650984, Dexamethasone, Pomalidomide)
Recruiting
- Plasma Cell Myeloma Refractory
- Isatuximab SAR650984
- +4 more
-
Chicago, Illinois
- +18 more
Aug 2, 2022
Sepsis CDS Master Enrollment Study Protocol
Recruiting
- Severe Sepsis
- Severe Sepsis Without Septic Shock
-
Augusta, Georgia
- +4 more
Jun 23, 2022